Who owns BRLI - BIO-REFERENCE LABS INC - COM $.01 NEW based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

BIO-REFERENCE LABS INC - COM $.01 NEW (BRLI) Institutional Ownership

Q: What is CUSIP 09057G602?

CUSIP 09057G602 is the security identifier used in SEC filing datasets for BRLI - BIO-REFERENCE LABS INC - COM $.01 NEW.

CUSIP: 09057G602

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2016

Type / Class: Equity / COM $.01 NEW
Symbol: BRLI

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 09057G602?
CUSIP 09057G602 identifies BRLI - BIO-REFERENCE LABS INC - COM $.01 NEW in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 09057G602:

Q2 2016 (0 holders) Q1 2016 (1 holder) Q4 2015 (0 holders) Q3 2015 (1 holder) Q2 2015 (180 holders) Q1 2015 (168 holders) Q4 2014 (178 holders) Q3 2014 (166 holders) Q2 2014 (166 holders) Q1 2014 (162 holders)

Institutional Holders of BIO-REFERENCE LABS INC - COM $.01 NEW (BRLI) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2016 Q2	0	$0	-$77,000				0
2016 Q1	2,183	$77,000	+$77,000			$35.27	1
2015 Q4	0	$0	-$193,000				0
2015 Q3	6,871	$193,000	-$839,416,602	$0	$0	$28.09	1
2015 Q2	20,368,020	$840,330,596	-$56,283,545	$13,942,000	$5,312,000	$41.25	180
2015 Q1	22,282,812	$784,943,337	-$21,326,463	$2,648,000	$18,120,000	$35.24	168
2014 Q4	23,129,478	$743,298,992	-$29,934,385	$8,447,000	$2,541,000	$32.13	178
2014 Q3	24,033,641	$674,389,350	-$26,236,931	$13,224,000	$4,409,000	$28.06	166
2014 Q2	24,866,077	$751,414,675	-$60,340,415	$7,104,000	$5,144,000	$30.22	166
2014 Q1	26,840,153	$742,941,404	+$56,435,482	$4,931,000	$19,395,000	$27.68	162